HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Torsten Dreier Selected Research

Glioblastoma (Glioblastoma Multiforme)

7/2014Four individually druggable MET hotspots mediate HGF-driven tumor progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Torsten Dreier Research Topics

Disease

11Neoplasms (Cancer)
06/2021 - 07/2002
3Carcinoma (Carcinomatosis)
07/2014 - 07/2002
2Autoimmune Diseases (Autoimmune Disease)
10/2018 - 07/2003
2Colorectal Neoplasms (Colorectal Cancer)
07/2014 - 06/2003
2Ovarian Neoplasms (Ovarian Cancer)
06/2003 - 06/2003
1Stomach Neoplasms (Stomach Cancer)
06/2021
1Hemorrhage
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020
1Myasthenia Gravis
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
11/2017
1Fatigue
11/2017
1Glioblastoma (Glioblastoma Multiforme)
07/2014
1Experimental Arthritis
06/2006
1Rheumatoid Arthritis
06/2006
1Lymphopenia (Lymphocytopenia)
05/2006
1Renal Cell Carcinoma (Grawitz Tumor)
02/2006
1Melanoma (Melanoma, Malignant)
02/2006

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
04/2016 - 07/2003
3Immunoglobulin G (IgG)IBA
01/2020 - 06/2003
3CytokinesIBA
04/2016 - 02/2006
3Epithelial Cell Adhesion MoleculeIBA
02/2006 - 06/2003
2ARGX-111IBA
06/2021 - 08/2015
2Pharmaceutical PreparationsIBA
06/2021 - 11/2017
2AutoantibodiesIBA
01/2019 - 10/2018
2Monoclonal AntibodiesIBA
11/2017 - 06/2003
2Proteins (Proteins, Gene)FDA Link
06/2006 - 02/2006
2Propidium (Propidium Iodide)IBA
06/2003 - 06/2003
1Inosine Triphosphate (ITP)IBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Cholinergic ReceptorsIBA
01/2019
1Immunoglobulin Fc FragmentsIBA
01/2019
1neonatal Fc receptorIBA
01/2019
1glucose-mannose-glucoseIBA
01/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2018
1insulin receptor-related receptor (IRR)IBA
11/2017
1Biological ProductsIBA
11/2017
1Biomarkers (Surrogate Marker)IBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
04/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2015
1LigandsIBA
08/2015
1Cytostatic AgentsIBA
08/2015
1Immune Checkpoint InhibitorsIBA
03/2014
1ErbB Receptors (EGF Receptor)IBA
08/2008
1Cetuximab (Erbitux)FDA Link
08/2008
1AlbuminsIBA
08/2008
1Single-Domain AntibodiesIBA
08/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2006
1Interleukin-2 (IL2)IBA
02/2006
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2006
1Surface Antigens (Surface Antigen)IBA
02/2006
1AntigensIBA
07/2003
1EdrecolomabIBA
07/2002

Therapy/Procedure

3Therapeutics
08/2015 - 06/2003
2Duration of Therapy
06/2021 - 11/2017
1Activities of Daily Living (ADL)
01/2019
1Plasma Exchange
10/2018
1Neoadjuvant Therapy
07/2014